Flow-mediated dilation in patients with left ventricular diastolic dysfunction

T Chigogidze1, G Simonia

  • 1Department of Internal Medicine, Tbilisi State Medical University.

Georgian Medical News
|December 22, 2005
PubMed

Insights

Endothelial dysfunction, indicated by reduced flow-mediated dilation (FMD), is present in patients with left ventricular diastolic dysfunction (LVDD). This FMD decrease may signal early-stage LVDD in coronary artery disease and hypertension patients.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Diabetology

Background:

  • Left ventricular diastolic dysfunction (LVDD) is a significant clinical condition.
  • Endothelial dysfunction is implicated in various cardiovascular diseases.
  • Early detection of LVDD is crucial for timely intervention.

Purpose of the Study:

  • To evaluate endothelium-dependent flow-mediated dilation (FMD) of the brachial artery in patients with LVDD.
  • To compare FMD in patients with LVDD due to coronary artery disease (CAD) and essential hypertension versus controls without LVDD.
  • To assess the correlation between FMD and post-isosorbide dinitrate (ISDN) vasodilation.

Main Methods:

  • Assessed FMD in 36 male patients with LVDD (22 with CAD, 14 with hypertension) and 18 male controls without LVDD.
  • Utilized brachial artery ultrasound to measure FMD.
  • Measured post-ISDN vasodilation to assess nitric oxide-independent vasodilation.

Main Results:

  • Patients with LVDD exhibited significantly decreased FMD compared to controls (4.67% vs. 6.12%, p<0.05).
  • FMD was significantly lower in both patient groups than in healthy subjects.
  • Post-ISDN vasodilation was similar between LVDD groups and lower than controls, showing no difference based on LVDD presence or cause.

Conclusions:

  • Endothelial dysfunction is evident in patients with diastolic dysfunction.
  • Depressed FMD may serve as an indicator of early-stage LVDD in patients with CAD and arterial hypertension.
  • FMD assessment is a valuable tool for identifying endothelial dysfunction associated with LVDD.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...